conbercept
Selected indexed studies
- Conbercept. (, 2006) [PMID:34292695]
- Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis. (Surv Ophthalmol, 2024) [PMID:38432359]
- Conbercept for patients with age-related macular degeneration: a systematic review. (BMC Ophthalmol, 2018) [PMID:29902977]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Conbercept. (2006) pubmed
- Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis. (2024) pubmed
- Conbercept for patients with age-related macular degeneration: a systematic review. (2018) pubmed
- Intravitreal conbercept as an adjuvant in vitrectomy for proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials. (2022) pubmed
- Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis. (2021) pubmed
- An update on conbercept to treat wet age-related macular degeneration. (2020) pubmed
- Intravitreal conbercept improves outcome in patients undergoing vitrectomy for proliferative diabetic retinopathy: A systematic review and meta-analysis. (2020) pubmed
- Comparison of clinical effectiveness of conbercept and ranibizumab for treating retinopathy of prematurity: a meta-analysis. (2023) pubmed
- Ranibizumab and conbercept for treating wet age-related macular degeneration in China: A systematic review and meta-analysis. (2021) pubmed
- Intravitreal Conbercept with Grid/Focal Photocoagulation for the Treatment of Diabetic Macular Edema: A Systematic Review and Meta-Analysis. (2022) pubmed